OPRE Evaluation - National and Tribal Evaluation of the 2nd Generation of the Health Profession Opportunity Grants [descriptive evaluation, impact evaluation, cost-benefit analysis study, pilot study]

ICR 202112-0970-002

OMB: 0970-0462

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2021-12-06
Justification for No Material/Nonsubstantive Change
2021-10-14
Supplementary Document
2021-05-19
Supplementary Document
2021-05-19
Supplementary Document
2021-05-19
Supplementary Document
2021-05-19
Supplementary Document
2021-10-13
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supplementary Document
2019-04-18
Supplementary Document
2020-06-24
Supplementary Document
2020-06-24
Supporting Statement B
2021-10-13
Supporting Statement A
2021-07-28
ICR Details
0970-0462 202112-0970-002
Received in OIRA 202110-0970-005
HHS/ACF OPRE
OPRE Evaluation - National and Tribal Evaluation of the 2nd Generation of the Health Profession Opportunity Grants [descriptive evaluation, impact evaluation, cost-benefit analysis study, pilot study]
No material or nonsubstantive change to a currently approved collection   No
Regular 12/07/2021
  Requested Previously Approved
07/31/2024 07/31/2024
7,298 7,298
2,977 2,977
0 0

Between August 2015 and July 2019, OMB has approved several information collection instruments, procedures and supporting materials in support of the HPOG 2.0 National and Tribal Evaluation. These include baseline data collection from all study participants, data collection protocols and procedures for the HPOG 2.0 Tribal Evaluation, and several instruments in support of the National Evaluation, including Short-Term and Intermediate Follow-up Surveys to support the HPOG 2.0 National Evaluation impact study. In July 2021, OMB approved Instrument 12a COVID-Cohort Short-term Survey (COVID-19 Cohort STS) and supporting materials. Since approval, the following events have led to the need for minor changes so some of the currently approved information collection. • OPRE’s Privacy Analyst reviewed the advance letter (Attachment K) and requested changes. An updated Attachment K is included with this request. • While preparing to program the COVID-19 Cohort STS (Instrument 12a), the team identified revisions to language that would help with the clarity of the request. The team also had a change in staffing resulting in a necessary update to contact information. An updated Instrument 12a is included with this request. • The success of the Intermediate Follow-up Survey Critical Items Only (Instrument 18a)—which was still underway at the time the COVID-19 Cohort STS was submitted to OMB for review and approval – led the team to create a similar Critical Items Instrument for the COVID-19 Cohort STS. This Critical Items Survey is labeled as Instrument 12b and is included with this request.

PL: Pub.L. 111 - 148 5507 , sec. 2008, (a)(3)(B) Name of Law: Patient Protection and Affordable Care Act
  
None

Not associated with rulemaking

  85 FR 83586 12/22/2020
86 FR 27624 05/21/2021
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 7,298 7,298 0 0 0 0
Annual Time Burden (Hours) 2,977 2,977 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The original burden estimate for Instrument 12a, the COVID-19 Cohort STS, was based on a presumed sample size of 7,500 study participants, a 75 percent response rate (5,625 responses), and a 60-minute length. The revised burden estimates reflect the same total number of responses (5,625), however, the overall response rate allows for 518 interviews to be completed using the shorter, critical items version of the COVID-19 Cohort STS (Instrument 12b). The shorter interview, the subject of this nonsubstantive change request, is estimated at just 20 minutes. The requested change reduces the original burden estimate for COVID-19 Cohort STS from 1,875 hours annually to 1,851 hours annually, a burden reduction of 6.2 percent annually. Burden estimates were reduced to 0 for Instrument 1 (PAGES Participant-level baseline data collection, tribal and non-tribal grantees) and for Instruments 18 and 18a now that the study enrollment and the Intermediate Follow-up survey data collection are complete.

$2,915,650
No
    Yes
    No
Yes
No
No
Yes
Molly Buck 202 205-4724 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/07/2021


© 2024 OMB.report | Privacy Policy